HuMab-7D8, a monoclonal antibody directed against the membrane-proximal small loop epitope of CD20 can effectively eliminate CD20 low expressing tumor cells that resist rituximab-mediated lysis.

T. van Meerten; H. Rozemuller; S. Hol; P. Moerer; M.C. Zwart; A. Hagenbeek; W.J.M. Mackus; P.W.H.I. Parren; J.G.J. van de Winkel; S.B. Ebeling; A.C.M. Martens

HuMab-7D8, a monoclonal antibody directed against the membrane-proximal small loop epitope of CD20 can effectively eliminate CD20 low expressing tumor cells that resist rituximab-mediated lysis.

T. van Meerten
, H. Rozemuller
, S. Hol
, P. Moerer
, M.C. Zwart
, A. Hagenbeek
, W.J.M. Mackus
, P.W.H.I. Parren
, J.G.J. van de Winkel
, S.B. Ebeling
, A.C.M. Martens

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Pages (from-to)	2063-2071
Number of pages	9
Journal	Haematologica
Volume	95
Issue number	12
Publication status	Published - 2010

Cite this

van Meerten, T., Rozemuller, H., Hol, S., Moerer, P., Zwart, M. C., Hagenbeek, A., Mackus, W. J. M., Parren, P. W. H. I., van de Winkel, J. G. J., Ebeling, S. B., & Martens, A. C. M. (2010). HuMab-7D8, a monoclonal antibody directed against the membrane-proximal small loop epitope of CD20 can effectively eliminate CD20 low expressing tumor cells that resist rituximab-mediated lysis. Haematologica, 95(12), 2063-2071.

@article{45fc928d2b734a7d91ed90c4e1e4a951,

title = "HuMab-7D8, a monoclonal antibody directed against the membrane-proximal small loop epitope of CD20 can effectively eliminate CD20 low expressing tumor cells that resist rituximab-mediated lysis.",

author = "\{van Meerten\}, T. and H. Rozemuller and S. Hol and P. Moerer and M.C. Zwart and A. Hagenbeek and W.J.M. Mackus and P.W.H.I. Parren and \{van de Winkel\}, J.G.J. and S.B. Ebeling and A.C.M. Martens",

year = "2010",

language = "English",

volume = "95",

pages = "2063--2071",

journal = "Haematologica",

issn = "0390-6078",

publisher = "Ferrata Storti Foundation",

number = "12",

}

van Meerten, T, Rozemuller, H, Hol, S, Moerer, P, Zwart, MC, Hagenbeek, A, Mackus, WJM, Parren, PWHI, van de Winkel, JGJ, Ebeling, SB & Martens, ACM 2010, 'HuMab-7D8, a monoclonal antibody directed against the membrane-proximal small loop epitope of CD20 can effectively eliminate CD20 low expressing tumor cells that resist rituximab-mediated lysis.', Haematologica, vol. 95, no. 12, pp. 2063-2071.

HuMab-7D8, a monoclonal antibody directed against the membrane-proximal small loop epitope of CD20 can effectively eliminate CD20 low expressing tumor cells that resist rituximab-mediated lysis. / van Meerten, T.; Rozemuller, H.; Hol, S. et al.
In: Haematologica, Vol. 95, No. 12, 2010, p. 2063-2071.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - HuMab-7D8, a monoclonal antibody directed against the membrane-proximal small loop epitope of CD20 can effectively eliminate CD20 low expressing tumor cells that resist rituximab-mediated lysis.

AU - van Meerten, T.

AU - Rozemuller, H.

AU - Hol, S.

AU - Moerer, P.

AU - Zwart, M.C.

AU - Hagenbeek, A.

AU - Mackus, W.J.M.

AU - Parren, P.W.H.I.

AU - van de Winkel, J.G.J.

AU - Ebeling, S.B.

AU - Martens, A.C.M.

PY - 2010

Y1 - 2010

M3 - Article

SN - 0390-6078

VL - 95

SP - 2063

EP - 2071

JO - Haematologica

JF - Haematologica

IS - 12

ER -